BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23510015)

  • 1. Suppression of autophagy by CUB domain-containing protein 1 signaling is essential for anchorage-independent survival of lung cancer cells.
    Uekita T; Fujii S; Miyazawa Y; Hashiguchi A; Abe H; Sakamoto M; Sakai R
    Cancer Sci; 2013 Jul; 104(7):865-70. PubMed ID: 23510015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.
    Uekita T; Jia L; Narisawa-Saito M; Yokota J; Kiyono T; Sakai R
    Mol Cell Biol; 2007 Nov; 27(21):7649-60. PubMed ID: 17785447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.
    Miyazawa Y; Uekita T; Hiraoka N; Fujii S; Kosuge T; Kanai Y; Nojima Y; Sakai R
    Cancer Res; 2010 Jun; 70(12):5136-46. PubMed ID: 20501830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility.
    Benes CH; Poulogiannis G; Cantley LC; Soltoff SP
    Oncogene; 2012 Feb; 31(5):653-63. PubMed ID: 21725358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulated adaptor protein p66(Shc) mitigates autophagy process by low nutrient and enhances apoptotic resistance in human lung adenocarcinoma A549 cells.
    Zheng Z; Yang J; Zhao D; Gao D; Yan X; Yao Z; Liu Z; Ma Z
    FEBS J; 2013 Sep; 280(18):4522-30. PubMed ID: 23815759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.
    Liu H; Ong SE; Badu-Nkansah K; Schindler J; White FM; Hynes RO
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1379-84. PubMed ID: 21220330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic Ras/ERK signaling activates CDCP1 to promote tumor invasion and metastasis.
    Uekita T; Fujii S; Miyazawa Y; Iwakawa R; Narisawa-Saito M; Nakashima K; Tsuta K; Tsuda H; Kiyono T; Yokota J; Sakai R
    Mol Cancer Res; 2014 Oct; 12(10):1449-59. PubMed ID: 24939643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases.
    Leroy C; Shen Q; Strande V; Meyer R; McLaughlin ME; Lezan E; Bentires-Alj M; Voshol H; Bonenfant D; Alex Gaither L
    Oncogene; 2015 Oct; 34(44):5593-8. PubMed ID: 25728678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel small molecule inhibiting CDCP1-PKCδ pathway reduces tumor metastasis and proliferation.
    Nakashima K; Uekita T; Yano S; Kikuchi JI; Nakanishi R; Sakamoto N; Fukumoto K; Nomoto A; Kawamoto K; Shibahara T; Yamaguchi H; Sakai R
    Cancer Sci; 2017 May; 108(5):1049-1057. PubMed ID: 28256037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdelta.
    He Y; Wortmann A; Burke LJ; Reid JC; Adams MN; Abdul-Jabbar I; Quigley JP; Leduc R; Kirchhofer D; Hooper JD
    J Biol Chem; 2010 Aug; 285(34):26162-73. PubMed ID: 20551327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirements for cub domain containing protein 1 (CDCP1) and Src dependent cell transformation.
    Kollmorgen G; Bossenmaier B; Niederfellner G; Häring HU; Lammers R
    PLoS One; 2012; 7(12):e53050. PubMed ID: 23300860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PM02734 (elisidepsin) induces caspase-independent cell death associated with features of autophagy, inhibition of the Akt/mTOR signaling pathway, and activation of death-associated protein kinase.
    Ling YH; Aracil M; Zou Y; Yuan Z; Lu B; Jimeno J; Cuervo AM; Perez-Soler R
    Clin Cancer Res; 2011 Aug; 17(16):5353-66. PubMed ID: 21690574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis.
    Uekita T; Sakai R
    Cancer Sci; 2011 Nov; 102(11):1943-8. PubMed ID: 21812858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migration.
    Razorenova OV; Finger EC; Colavitti R; Chernikova SB; Boiko AD; Chan CK; Krieg A; Bedogni B; LaGory E; Weissman IL; Broome-Powell M; Giaccia AJ
    Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1931-6. PubMed ID: 21233420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis.
    Chiu KL; Lin YS; Kuo TT; Lo CC; Huang YK; Chang HF; Chuang EY; Lin CC; Cheng WC; Liu YN; Lai LC; Sher YP
    Oncotarget; 2017 Jul; 8(29):47365-47378. PubMed ID: 28537886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis.
    Chiu KL; Kuo TT; Kuok QY; Lin YS; Hua CH; Lin CY; Su PY; Lai LC; Sher YP
    Sci Rep; 2015 Nov; 5():16426. PubMed ID: 26553452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue transglutaminase inhibits autophagy in pancreatic cancer cells.
    Akar U; Ozpolat B; Mehta K; Fok J; Kondo Y; Lopez-Berestein G
    Mol Cancer Res; 2007 Mar; 5(3):241-9. PubMed ID: 17374730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells.
    Casar B; He Y; Iconomou M; Hooper JD; Quigley JP; Deryugina EI
    Oncogene; 2012 Aug; 31(35):3924-38. PubMed ID: 22179830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of inside-out β1-integrin activation by CDCP1.
    Pollan SG; Huang F; Sperger JM; Lang JM; Morrissey C; Cress AE; Chu CY; Bhowmick NA; You S; Freeman MR; Spassov DS; Moasser MM; Carter WG; Satapathy SR; Shah K; Knudsen BS
    Oncogene; 2018 May; 37(21):2817-2836. PubMed ID: 29511352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer.
    Wright HJ; Arulmoli J; Motazedi M; Nelson LJ; Heinemann FS; Flanagan LA; Razorenova OV
    Oncogene; 2016 Sep; 35(36):4762-72. PubMed ID: 26876198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.